VYCOThe NovaVision Solution
NovaVision, a wholly-owned subsidiary of Vycor Medical, provides the first real hope for those who suffer
partial "permanent" blindness due to stroke or TBI - these individuals constitute approximately 16% of all stroke
and TBI victims. This hope comes in the form of a computer-based "vision restoration therapy" product (VRT).
NovaVision’s VRT is an FDA-cleared medical device and both its VRT and NeET products have CE clearance
for rehabilitation of vision-field loss resulting from neurological damage. The Company's VRT product is a
patient-specific diagnostic and therapeutic platform with extensive clinical data supporting its ability to increase
a patient’s visual field; more than 2,000 patients have been treated with VRT as of today. Use of recentlyacquired
SightScience's NeET has also been shown to increase visual sensitivity within the blind field in clinical
studies and is marketed in the EU. Note that all other vision therapies available today focus on vision-loss
compensation and substitution such as prisms, making NovaVision's products the only commercially-viable,
clinically-supported alternative that actual restores some degree of "permanently" lost sight. In our view this
constitutes a legitimate medical break-through that should eventually improve the lives of millions.
NovaVision's VRT product uses computer-generated light patterns to stimulate nerves in or near the brain's
optical centers, where light is processed and interpreted. Over fifteen years of clinical research, it has been
shown that in approximately 70% of cases patients using NovaVision's VRT system over a three to six
month period experience significant recovery in at least one functional outcome. In many cases this
recovery is enough to restore lost abilities such as reading, avoiding unseen objects while walking, or in some
cases even driving a car. Although this therapy addresses only 16% of stroke and TBI cases, this still represents
a huge market for Company of this size. As the Company's VRT system becomes widely adopted by
physicians, rehabilitation centers, physician centers, and by the patients they treat, it should permanently change
. http://www.novavision.com
VYCOThe NovaVision Solution NovaVision, a wholly-owned
Top 10 Most Recent News Articles
OMLYCLO Shakes Up U.S. Biologic Market as Key Player
Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...
Continue Reading
Aging at Home: The Real Costs and Obstacles Ahead
Facing the Realities of Aging In Place Alright, let's talk straight. Everyone dreams of staying home in their twilight years, kicking back in their favorite chair with family nearby. But the harsh truth? That comfort comes with a price tag. According to Northwestern Mutual's 2026 Planning & Progress Study, up to 83% of Boomers+ and most other generations fancy the idea of...
Continue Reading
GL1F Crypto: A Breakthrough in On-Chain AI for Crypto
The Dawn of On-Chain Machine Learning In a world where crypto folks often tout decentralization like it’s the holy grail, GenesisL1 is throwing open the doors to a new kind of crypto playground with GL1F Crypto. A decentralized on-chain AI studio? Sounds like sci-fi, but here we are—hands on the precipice of democratized machine learning in your browser. A Lab in...
Continue Reading
Indiana American Water's PFAS Credits Total $25.5M
Indiana American Water Dishes Out Big Buck Refunds Swing by Indiana American Water's latest move, and what do you see? A whopping $25.5 million in PFAS settlement credits being doled out to customers. That's right, this ain't your everyday water utility story—there's real money on the line here. Over four rounds of bill credits since November 2025, customers have seen...
Continue Reading
#L.A. Rising Podcast: From Fires to International Fame
From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...
Continue Reading
Event Industry Power 50 Voting Surge Ahead of Close
An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....
Continue Reading
Travelers Turn to Direct Booking Amid Cost Surge
Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...
Continue Reading
Hiromi Asai's Akatsuki Shines at Paris Fashion Week
An Ode to Tradition Amid Modern Menswear From the bustling avenues of New York to the storied streets of Paris, Hiromi Asai is showcasing something that strikes a chord deep in the fashion industry's soul. Her Spring/Summer 2027 collection, "Akatsuki — Before the Dawn," takes its rare blend of age-old Japanese textile craftsmanship across the pond to the City of Light....
Continue Reading
Palm Beach Royals Boost Pickleball's Popularity Surge
A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...
Continue Reading
TRIMAX Poised to Meet AI-Driven Power Challenges
TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...
Continue ReadingTop 5 Most Recently Viewed Articles
Armstrong Company Sees Leadership Shake-Up for Growth
New Leadership at The Armstrong Company It’s about time. Armstrong’s rolling out fresh faces in the top spots. Todd Watson’s stepping down as CEO, but don’t get it twisted—he’s not leaving the building; he’s now co-chair along with his cousin Mark Pickens. These guys are the latest entries in a long line of leadership dating back to their founders in 1957....
Continue Reading
NVIDIA Prepares for Q3 Financial Results Conference
NVIDIA's Upcoming Conference Call for Financial Results NVIDIA is gearing up to connect with stakeholders through a conference call planned for a future date. This call will focus on discussing the financial results for the company's third quarter of the current fiscal year. Investors and analysts will have the opportunity to gain insights into the financial landscape of...
Continue Reading
Free Heart and Kidney Health Screenings Set for January in Seattle
Free Heart and Kidney Health Screenings in Seattle Residents of Seattle have a valuable opportunity coming up with the Heart & Kidney Health Screening initiative offered by Care Access. This program aims to enhance awareness of crucial health risk factors, particularly the dangerous lipoprotein(a), often abbreviated as Lp(a). Affecting one in five individuals, high Lp(a)...
Continue Reading
Important Legal Notification for Replimune Group Investors
Protect Your Investment with Legal Guidance In the fast-paced world of investing, timely information is crucial for making informed decisions. This is especially true for investors in Replimune Group, Inc. (NASDAQ: REPL) who have participated in transactions within recent class periods. Understanding your rights and options can significantly affect your financial future....
Continue Reading
Class Action Alert: Kyverna Therapeutics Investors Take Note
Important Opportunity for Kyverna Therapeutics, Inc. Investors Kyverna Therapeutics, Inc. (NASDAQ: KYTX) provides a significant opportunity for its shareholders due to a potential class action lawsuit concerning possible securities fraud. If you're someone who purchased common stock during the company’s initial public offering (IPO), you might be entitled to...
Continue Reading